Review

Published on 05 Dec 2022

Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance

in Cancer Immunity and Immunotherapy

Veronika Voronova
Anastasia Vislobokova
Kerim Mutig
Mikhail Samsonov
Kirill Peskov
Marina Sekacheva
Maria Materenchuk
Natalya Bunyatyan
Svetlana Lebedeva

Frontiers in Oncology

doi 10.3389/fonc.2022.1035884

6,981 views
19 citations

Original Research

Published on 05 Dec 2022

The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma

in Cancer Immunity and Immunotherapy

Guojie Zhao
Changjing Wang
Jian Jiao
Wei Zhang
Hongwei Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1045477

4,022 views
3 citations

Case Report

Published on 02 Dec 2022

Extremely high infiltration of CD8+PD-L1+ cells detected in a stage III non-small cell lung cancer patient exhibiting hyperprogression during anti-PD-L1 immunotherapy after chemoradiation: A case report

in Cancer Immunity and Immunotherapy

Changshun Wu
Kai Zhou
Yan Zheng
Dongxiao Lv
Miaoqing Zhao
Yue Hu
Fei Qi
Xin Wang
Hong Feng

Frontiers in Oncology

doi 10.3389/fonc.2022.969493

2,559 views
1 citation

Opinion

Published on 02 Dec 2022

Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

in Cancer Immunity and Immunotherapy

Hong Qin
Changqiao You
Feng Yan
Kefang Tan
Changgen Xu
Rui Zhao
Marlene Davis Ekpo
Songwen Tan

Frontiers in Oncology

doi 10.3389/fonc.2022.1062765

1,611 views
1 citation

Original Research

Published on 02 Dec 2022

NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation

in Cancer Immunity and Immunotherapy

Robin S. Lindsay
Marit M. Melssen
Katarzyna Stasiak
Jessica L. Annis
Amber N. Woods
Anthony B. Rodriguez
Michael G. Brown
Victor H. Engelhard

Frontiers in Oncology

doi 10.3389/fonc.2022.1058894

2,497 views
1 citation

Original Research

Published on 01 Dec 2022

A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma

in Cancer Immunity and Immunotherapy

Lina Zhang
Song Wu
Junjie Huang
Yanbin Shi
Yuesong Yin
Xu Cao

Frontiers in Oncology

doi 10.3389/fonc.2022.1085065

3,933 views
6 citations

Review

Published on 01 Dec 2022

Emerging role of Protein Kinase CK2 in Tumor immunity

in Cancer Immunity and Immunotherapy

Leichong Chen
Sijia Zhang
Qianwen Li
Junyu Li
Huilin Deng
Sheng Zhang
Rui Meng

Frontiers in Oncology

doi 10.3389/fonc.2022.1065027

3,891 views
2 citations

Original Research

Published on 30 Nov 2022

DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma

in Cancer Immunity and Immunotherapy

Yumin Ke
LiuXia You
YanJuan Xu
Dandan Wu
Qiuya Lin
Zhuna Wu

Frontiers in Oncology

doi 10.3389/fonc.2022.1084192

2,545 views
5 citations

Original Research

Published on 29 Nov 2022

Single-cell analyses reveal the therapeutic effects of ATHENA and its mechanism in a rhabdomyosarcoma patient

in Cancer Immunity and Immunotherapy

Yujun Liu
Ke Wang
Yanli Zhou
Xibing Zhuang
Shali Shao
Fulu Qiao
Xiangdong Wang
Xin Zou
Tiankui Qiao

Frontiers in Oncology

doi 10.3389/fonc.2022.1039145

2,978 views

Review

Published on 29 Nov 2022

Chimeric antigen receptor T-cell therapy for T-ALL and AML

in Cancer Immunity and Immunotherapy

Wenwen Wei
Dong Yang
Xi Chen
Dandan Liang
Liqun Zou
Xudong Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.967754

8,505 views
20 citations

Case Report

Published on 25 Nov 2022

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review

in Cancer Immunity and Immunotherapy

Qiaoyun Tan
Lichao Liu
Yu Huang
Xiaorong Dong
Lingjuan Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.973421

2,955 views
4 citations

Original Research

Published on 24 Nov 2022

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

H. S. Gabryś
L. Basler
S. Burgermeister
S. Hogan
M. Ahmadsei
M. Pavic
M. Bogowicz
D. Vuong
S. Tanadini-Lang
R. Förster

Frontiers in Oncology

doi 10.3389/fonc.2022.977822

2,299 views
4 citations

Review

Published on 24 Nov 2022

Recent advances in the progress of immune checkpoint inhibitors in the treatment of advanced gastric cancer: A review

in Cancer Immunity and Immunotherapy

Jingjing Shen
Zhongming Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.934249

2,412 views
6 citations

Original Research

Published on 22 Nov 2022

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

in Cancer Immunity and Immunotherapy

Uffe Klausen
Jacob Handlos Grauslund
Nicolai Grønne Dahlager Jørgensen
Shamaila Munir Ahmad
Merete Jonassen
Stine Emilie Weis-Banke
Evelina Martinenaite
Lone Bredo Pedersen
Thomas Landkildehus Lisle
Anne Ortved Gang

Frontiers in Oncology

doi 10.3389/fonc.2022.1023015

1,988 views
2 citations

Original Research

Published on 22 Nov 2022

The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma

in Cancer Immunity and Immunotherapy

Fan Chen
Min Chao
Tao Huang
Shaochun Guo
Yulong Zhai
Yuan Wang
Na Wang
Xuan Xie
Liang Wang
Peigang Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.1055783

2,040 views
2 citations

Original Research

Published on 21 Nov 2022

Dynamic alterations in PD-1/PD-L1 expression level and immune cell profiles based on radiation response status in mouse tumor model

in Cancer Immunity and Immunotherapy

Yi Na Yoon
Min Ho Choe
Moonkyoo Kong
Weon Kuu Chung
Jae-Sung Kim
Yu Jin Lim

Frontiers in Oncology

doi 10.3389/fonc.2022.989190

2,246 views
2 citations

Navigation group

Articles

Combination of immune checkpoint inhibitors with radiation therapy in cancer: A hammer breaking the wall of resistance

The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma

Extremely high infiltration of CD8+PD-L1+ cells detected in a stage III non-small cell lung cancer patient exhibiting hyperprogression during anti-PD-L1 immunotherapy after chemoradiation: A case report

Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

NK cells reduce anergic T cell development in early-stage tumors by promoting myeloid cell maturation

A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma

Emerging role of Protein Kinase CK2 in Tumor immunity

DPP6 and MFAP5 are associated with immune infiltration as diagnostic biomarkers in distinguishing uterine leiomyosarcoma from leiomyoma

Single-cell analyses reveal the therapeutic effects of ATHENA and its mechanism in a rhabdomyosarcoma patient

Chimeric antigen receptor T-cell therapy for T-ALL and AML

Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors

Recent advances in the progress of immune checkpoint inhibitors in the treatment of advanced gastric cancer: A review

Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV

The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma

Dynamic alterations in PD-1/PD-L1 expression level and immune cell profiles based on radiation response status in mouse tumor model